Blog
Is Cisco an Undervalued Dividend Stock After Its Q1 Earnings Beat?
Cisco's (NASDAQ: CSCO) stock recently popped after the networking hardware and software leader posted its first-quarter numbers.
Its revenue declined 9% year over year to $11.9 billion, beating
5 Must-Follow Rules for Building a Winning Investment Portfolio
Investing is one of the surest ways to build wealth -- if you do it wisely. The good news is, it doesn't have to be that hard to build a portfolio that should perform well for you over the long
Will a Coronavirus Vaccine Stop the Momentum of These Gaming Stocks?
Electronic Arts, Activision Blizzard, and Take-Two Interactive have seen their share prices outperform for much of the year, but some investors may be wondering whether Pfizer and Moderna's
Better Buy: Amazon vs. PepsiCo
Amazon (NASDAQ: AMZN) and PepsiCo (NASDAQ: PEP) are fortunate to benefit from sales growth during the coronavirus pandemic. That is not to say they are not facing challenges. Amazon is investing
MercadoLibre, Bill.com, and Green Dot: 3Q Earnings Rundown
We've now heard third-quarter earnings from most of our favorite companies. Three in particular that investors might want to pay attention to are MercadoLibre (NASDAQ: MELI), Bill.com (NYSE: BILL)
Could Canopy Growth Be a Millionaire-Maker Stock?
Those who bought (and held) the Canadian shares of pot producer Canopy Growth (TSX: WEED) (NYSE: CGC) in early 2014 have seen their stock's value increase by a cumulative 1,490% as of Nov. 12.
This Social Security Misconception Could Leave You Desperate for Money in Retirement
"Social Security will replace my former paycheck once I retire, right?"
Wrong.
Many people go through their working years without taking the time to learn about Social Security. They tend to miss
Is Cognex Stock a Buy?
Machine vision company Cognex (NASDAQ: CGNX) is definitely not a company that looks cheap at first glance. Trading at 67 times current earnings, it's hard to make the case that the stock is a great
3 Surefire Stocks to Buy If the Market Crashes
Stock market swoons occur, but predicting when they'll happen or how long share prices will remain depressed is extraordinarily difficult. However, when the overall market declines, a buying
Internet of Things and 5G Stock Sierra Wireless Is Still in a Slump -- For Now
The share price of Internet of Things (IoT) company Sierra Wireless (NASDAQ: SWIR) has been languishing the last couple of years. And although the company has made some announcements regarding 5G
Here's Why Berkshire Hathaway's $9 Billion Buyback Is So Significant
When Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) reported its third-quarter earnings, investors were surprised to discover the company bought back more than $9 billion of its own stock.
In this
Moderna's and Pfizer's Vaccine News May Signal a Market Top
This has been a huge month for news, and Wall Street and has been taking in every drop of it. On election night, we learned that five states had legalized marijuana in some capacity, and found out
Why Amazon Stock Should Be on Your Holiday Shopping List
Our experts issued a rare "Double Down" Buy alert on this one stock... Learn more.
This holiday shopping season is shaping up to be unlike any other we've seen. First of all, it's already well
PayPal's Third Quarter Was Strong -- But Can the Growth Continue?
PayPal (NASDAQ: PYPL) reported some impressive numbers for the third quarter and added millions of active users to its platform. But how much bigger could it get?
In this Fool Live video from our
SpaceX President Prefers Space Tugs Over Small Rockets
Euroconsult's World Satellite Business Week Virtual event just might have been the most important conference that space investors never heard of.
Held last week entirely online, this conference
Robinhood Investors Love Square. Should They?
Square (NYSE: SQ) is one of the hottest stocks on Wall Street, gaining over 350% over the past three years and roughly 200% this year alone. It's an exciting company, which makes it attractive to
2 Reasons Why Moderna's Coronavirus Vaccine Candidate Just Took the Lead Away from Pfizer
Our experts issued a rare "Double Down" Buy alert on this one stock... Learn more.
Pfizer (NYSE: PFE) wowed the world last week when it reported positive interim efficacy data from phase 3 trials of
Better Buy: Realty Income vs. STORE Capital
A lot has changed in the real estate investment trust (REIT) space since positive coronavirus vaccine news led to a big sector rally. One notable change has been in the relative appeal of net-lease
Getting a Holiday Bonus at Work? How to Make the Most of It
Image source: Getty Images.
While it doesn't influence our opinions of products, we do receive compensation from partners whose offers appear here. We're on your side, always. See our full
The Motley Fool Sits Down With A Doctor About Pfizer's Coronavirus Vaccine News
Pfizer (NYSE: PFE) and its German partner BioNTech (NASDAQ: BNTX) reported incredible efficacy data from a phase 3 trial for their mRNA coronavirus vaccine candidate last Monday. While the 90%
Why Is Everyone Talking About Moderna Stock?
When Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX) announced last week that the vaccine candidate they had developed was 90% effective at preventing COVID-19 infection, the market (and everyone
2 Great Dividend Stocks Whose Payouts Could Double
Are you looking for some solid, recurring income that can help your portfolio grow over the years? Dividend stocks can do just that, especially those that increase their payouts over time. If your
3 of the Biggest Long-Term Winners of the COVID-19 Pandemic
The COVID-19 pandemic has battered the U.S. economy, but its impact has been uneven. Some companies have clearly benefited. Videoconferencing, collaboration software, home fitness, and telemedicine
Surprise: You Might Pay More for Your Medicare Part D Drug Plan in 2021
One major misconception about Medicare is that the program is free for enrollees, but that's just plain not true. While Part A, which covers hospital care, is generally free, Parts B and D, which
These 3 Medical Device Stocks Leave Biotech in the Dust
Even though the biotech sector's coronavirus vaccine efforts have dominated the 2020 news cycle, those stocks don't always beat the market. When it comes to consistent profitability, long-term


